
November 4 - 6, 2011
Bethesda North Marriott Hotel & Conference Center
North Bethesda, MD
Tuesday, November 1 - Wednesday, Nov 2 |
||
| Summit on Cell Therapy for Cancer (Held at the Masur Auditorium, on the NIH Campus) For more information, click here. |
||
Thursday, November 3 |
||
| 8:00 am - 5:00 pm | Workshop on Immunotherapy Combinations For more information, click here. |
|
| 8:00 am - 5:00 pm | Primer on Tumor Immunology and Cancer Immunotherapy For more information, please click here. |
|
Friday, November 4 (26th Annual Meeting Begins) |
||
| 7:50 am - 8:00 am | President's Welcome Thomas F. Gajewski, MD, PhD - University of Chicago |
|
| 8:00 am - 8:45 am | Richard V. Smalley, MD Memorial Lectureship Vaccines That Target Dendritic Cells Ralph M. Steinman, MD - The Rockefeller University Speaker : TBD |
|
| 8:45 am - 11:30 am |
Plenary Session: Biology & Application of Dendritic Cells Co-Chairs: Nina Bhardwaj, MD, PhD - NYU Medical Center Viggo Van Tendeloo, PhD - Antwerp University Hospital Invited Speakers: Nina Bhardwaj, MD, PhD - NYU Medical Center Robert Seder, MD - NIAID, NIH Viggo Van Tendeloo, PhD - Antwerp University Hospital |
|
| 11:30 am - 12:00 pm | Plenary Session: To Be Announced | |
| 12:00 pm - 1:30 pm | Lunch Break & Poster Viewing | |
| 1:30 pm - 3:00 pm |
Concurrent Session I: Immunology of Cancer Stem Cells and Epithelial-to-Mesenchymal Transition (EMT) Co-Chairs: Malcolm A.S. Moore, D.Phil - Memorial Sloan-Kettering Cancer Center Jeffrey Schlom, PhD - National Cancer Institute, NIH Invited Speakers: Malcolm A.S. Moore, D.Phil - Memorial Sloan-Kettering Cancer Center Claudia M. Palena, PhD - National Cancer Institute, NIH |
|
| 1:30 pm - 3:00 pm |
Concurrent Session II: Uncoupling Negative Regulation in the Tumor Microenvironment Co-Chairs: Lieping Chen, MD, PhD - Yale University Hassane M. Zarour, MD - University of Pittsburgh Invited Speakers: Lieping Chen, MD, PhD - Yale University Hassane M. Zarour, MD - University of Pittsburgh |
|
| 3:15 pm - 5:15 pm |
Plenary Session: Genetically Engineered Receptors and Adoptive Cell Therapies Co-Chairs: Carl H. June, MD - University of Pennsylvania Dolores J. Schendel, PhD - Helmholz Zentrum Muenchen - German Research Center for Environmental Health Invited Speakers: Laurence J.N. Cooper, MD, PhD - MD Anderson Cancer Center Carl H. June, MD - University of Pennsylvania Dolores J. Schendel, PhD - Helmholz Zentrum Muenchen - German Research Center for Environmental Health |
|
| 5:15 pm - 5:45 pm | Plenary Session: Cancer Immunotherapy Trials Network (CITN) Update Speaker: Mary L. (Nora) Disis, MD - Co-Principal Investigator, Cancer Immunotherapy Trials Network (CITN); University of Washington |
|
| 5:45 pm - 6:15 pm | SITC Membership Business Meeting | |
| Immediately Following the Business Meeting 8:00 pm |
Poster & Networking Reception | |
Saturday, November 5 |
||
| 8:00 am - 8:45 am | Keynote Address: Innate Immune Recognition of Nucleic Acids Katherine Fitzgerald, PhD - University of Massachusetts Medical School |
|
| 8:45 am - 11:30 am |
Plenary Session: Characterization of Inflammatory Infiltrates in Human Cancers Co-Chairs: George Coukos, MD, PhD - University of Pennsylvania Medical Center Wolf-Hervé Fridman, MD, PhD - INSERM Invited Speakers: Vincenzo Bronte, MD - Verona University - Immunology Section George Coukos, MD, PhD - University of Pennsylvania Medical Center Wolf-Hervé Fridman, MD, PhD - INSERM |
|
| 11:30 am - 12:00 pm | Plenary Session: Late Breaking Abstracts | |
| 12:00 pm - 1:30 pm | Lunch Break & Poster Viewing | |
| 1:30 pm - 3:00 pm |
Concurrent Session I: State of the Art Animal Models and Veterinary Applications for Cancer and Immunology Co-Chairs: Thomas Blankenstein, PhD - Max-Delbruck Center for Molecular Medicine Jedd D. Wolchok, MD, PhD - Memorial Sloan-Kettering Cancer Center Invited Speakers: Thomas Blankenstein, PhD - Max-Delbruck Center for Molecular Medicine Taha Merghoub, PhD - Memorial Sloan-Kettering Cancer Center |
|
| 1:30 pm - 3:00 pm |
Concurrent Session II: High Throughput Technologies for Immune Monitoring Co-Chairs: Philipp Beckhove, MD - German Cancer Research Center Sacha Gnjatic, PhD - Ludwig Institute for Cancer Research Invited Speakers: Philipp Beckhove, MD - German Cancer Research Center Sacha Gnjatic, PhD - Ludwig Institute for Cancer Research |
|
| 3:15 pm - 4:50 pm |
Presidential Abstract Session Chair: Thomas F. Gajewski, MD, PhD - University of Chicago |
|
| 4:50 pm - 5:20 pm | Clinical Immunotherapy Guidelines Update Speaker: Howard L. Kaufman, MD - Rush University Medical Center |
|
| 5:20 pm - 5:35 pm | National Cancer Institute, NIH Update Speaker: William Merritt, PhD - National Cancer Institute |
|
| 5:35 pm - 5:50 pm | FDA Update on Regulatory Issues Related to Cancer Immunotherapy Speaker: Raj K. Puri, MD, PhD - Food and Drug Administration, CBER |
|
| 5:50 pm - 6:15 pm | Award Presentations | |
|
6:15 pm - 8:00 pm |
Presidential Reception with Poster Viewing |
|
| After 8:00 pm/ Presidential Reception |
Performance by the band The Checkpoints | |
Sunday, November 6 |
||
| 8:00 am - 10:15 am |
Plenary Session: Prostate Cancer as a Learning Model Co-Chairs: Charles G. Drake, MD, PhD - Johns Hopkins University James L. Gulley, MD, PhD - National Cancer Institute Invited Speakers: Charles G. Drake, MD, PhD - Johns Hopkins University James L. Gulley, MD, PhD - National Cancer Institute Douglas G. McNeel, MD, PhD - University of Wisconsin |
|
| 10:15 am | Annual Meeting Adjourns | |
| 10:15 am - 12:00 pm | Hot Topic Symposium: Targeting the Next Generation of Inhibitory Pathways | |